Research summary ·
Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This paper is a regional guideline on nerve damage caused by diabetes. It covers the Gulf Cooperation Council region, called the GCC. A panel of 12 diabetes experts from GCC countries took part. They used a Delphi method, which means several rounds of voting. First they read world guidelines and named care needs not yet met. Then they voted on statements about testing, diagnosis and care.
What they found
The experts agreed strongly that care needs to act early, not wait for symptoms. They backed a yearly check for all people with diabetes. People with prediabetes were also included in this yearly check. The panel stressed early care that joins several parts together. This includes lifestyle changes and lowering heart risk. It also includes drugs that target the cause of the nerve damage. Pain drugs were to be chosen for each person. The panel also named some barriers. These were short visits, heavy workload and low awareness. Rules that limit access to some drugs were also a barrier.
What it means for patients
The guideline says GCC doctors can check everyone with diabetes or prediabetes yearly. It says care can start early and mix several kinds of help. The authors see a need for the same care across the region. They say regular testing, early care and better drug access may help. In their view, this may improve daily life and lower problems from the disease.
Why it is not certain yet
This guideline is based on expert views, not on a new study of patients. The panel had 12 experts. The abstract does not show how well these steps work in real care. The authors name barriers like short visits and limited drug access. These may make the advice hard to put into use.
Source
Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council.
PubMed · PMID 42557853We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Diabetic neuropathy publications